ARCHIVES

NCI Plans Preclinical Studies Of Endoxifen, A Tamoxifen Metabolite.

This article is from The Cancer Letter archive.

Vol. 35 No. 31 | August 7, 2009

Download PDF Visit The Full Archive

Related Articles

Practice of Oncology Must Incorporate Clinical Research, NCI Director Tells ASCO

May 30, 1997

Teddy DeVita’s Courageous Fight Ends At Age 17

June 6, 1980

Skipper’s Impact: Drugs Curing 40,000 a Year

March 27, 1981

Oncology Nursing Exam to Be Offered In 1990; 79% Passed Last Year

November 24, 1989

NIH institute directors, in response to question from Sen. Arlen Specter, say Bush Administration’s stem cell research policy is harmful to NIH leadership in science.

April 8, 2005

AstraZeneca To Pay $335M In Illegal Pricing Penalties.

June 27, 2003